LigaChem Biosciences Hosts 2026 Global R&D Day IR, Unveils Mid-to-Long Term Business Strategy
LigaChem Biosciences will hold its Global R&D Day IR on July 8, 2026, at Yeouido and via YouTube live.
The event covers partner clinical development updates, internal R&D progress, new research topics, and mid-to-long term business development strategy.
The presentation and Q&A session target analysts, investors, and media.
No capital changes or shareholder return policies are disclosed in this document.
[AI Summary]This IR event is a routine communication to share the company's R&D pipeline and strategy, with no immediate financial impact on shareholder value. While it provides valuable information for long-term investment decisions, it does not alter the capital structure or short-term stock price.